Literature DB >> 28776928

Patients with Parkinson disease present high ambulatory blood pressure variability.

Hélcio Kanegusuku1, Carla Silva-Batista1, Tiago Peçanha1, Natan Silva-Junior1, Andreia Queiroz1, Luiz Costa1, Marco Mello2, Maria Piemonte3, Carlos Ugrinowitsch1, Cláudia Forjaz1.   

Abstract

Patients with Parkinson disease (PD) present blunted nocturnal blood pressure fall and similar ambulatory blood pressure variability (ABPV) measured by standard deviation (SD) and coefficient of variation (CV) compared with healthy subjects. However, these classical indices of ABPV have limited validity in individuals with circadian blood pressure alterations. New indices, such as the average of daytime and night-time standard deviation weighted by the duration of the daytime and night-time intervals (SDdn ) and the average real variability (ARV), remove the influence of the daytime and the night-time periods on ABPV. This study assessed ABPV by SDdn and ARV in PD. Twenty-one patients with PD (11 men, 66 ± 2 years, stages 2-3 of modified Hoehn &amp; Yahr) and 21 matched controls without Parkinson disease (9 men, 64 ± 1 years old) underwent blood pressure monitoring for 24 h. ABPV was analysed by 24 h, daytime and night-time SD and CV, and by the SDdn and ARV. Systolic/diastolic 24-h and night-time SD and CV were similar between the patients with PD and the controls. The patients with PD presented higher daytime systolic/diastolic CV and SD than the controls (10·4 ± 0·9/12·3 ± 0·8 versus 7·0 ± 0·3/9·9 ± 0·5%, P<0·05; 12·6 ± 1·0/9·1 ± 0·5 versus 8·6 ± 0·4/7·5 ± 0·3 mmHg, P<0·05, respectively) as well as higher systolic/diastolic SDdn (10·9 ± 0·8/8·2 ± 0·5 versus 8·2 ± 0·3/7·1 ± 0·2 mmHg, P<0·05, respectively) and ARV (8·8 ± 0·6/6·9 ± 0·3 versus 7·2 ± 0·2/6·0 ± 0·2 mmHg, P<0·05, respectively). In conclusion, patients with PD have higher ABPV than control subjects as assessed by SDd , CVd , SDdn and AVR.
© 2016 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Parkinsonism; ambulatory blood pressure; circadian blood pressure; circadian variability; nocturnal blood pressure fall

Mesh:

Year:  2016        PMID: 28776928     DOI: 10.1111/cpf.12338

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  8 in total

1.  Effects of Endurance Training on Motor Signs of Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Filipe Oliveira de Almeida; Vagner Santana; Daniel M Corcos; Carlos Ugrinowitsch; Carla Silva-Batista
Journal:  Sports Med       Date:  2022-02-03       Impact factor: 11.928

2.  Parkinson patients without tremor show changed patterns of mechanical muscle oscillations during a specific bilateral motor task compared to controls.

Authors:  Laura V Schaefer; Frank N Bittmann
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

3.  24-hour ambulatory blood pressure alterations in patients with Parkinson's disease.

Authors:  Liwei Shen; Xiaoli Yang; Wenmei Lu; Weijie Chen; Xiaofei Ye; Danhong Wu
Journal:  Brain Behav       Date:  2021-11-28       Impact factor: 2.708

4.  Case-control study of hypertension and Parkinson's disease.

Authors:  Yuen-Fann Ng; Ebonne Ng; Ee-Wei Lim; Kumar M Prakash; Louis C S Tan; Eng-King Tan
Journal:  NPJ Parkinsons Dis       Date:  2021-07-21

Review 5.  Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation.

Authors:  Yufei Liu; Long Niu; Xinyao Liu; Cheng Cheng; Weidong Le
Journal:  Neurosci Bull       Date:  2021-06-15       Impact factor: 5.271

Review 6.  Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases.

Authors:  Palanivel Ganesan; Prakash Ramalingam; Govindarajan Karthivashan; Young Tag Ko; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2018-03-15

7.  Parkinson-like early autonomic dysfunction induced by vagal application of DOPAL in rats.

Authors:  Jie Sun; Chao He; Qiu-Xin Yan; Hong-Dan Wang; Ke-Xin Li; Xun Sun; Yan Feng; Rong-Rong Zha; Chang-Peng Cui; Xue Xiong; Shan Gao; Xue Wang; Rui-Xue Yin; Guo-Fen Qiao; Bai-Yan Li
Journal:  CNS Neurosci Ther       Date:  2021-01-21       Impact factor: 5.243

Review 8.  Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence.

Authors:  Lorena Cuenca-Bermejo; Pilar Almela; Javier Navarro-Zaragoza; Emiliano Fernández Villalba; Ana-María González-Cuello; María-Luisa Laorden; María-Trinidad Herrero
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.